Trellus Health
TRLS · AIM · Health Care · mcap £0.5m · 0.1p 1 open situation →
Timeline · every situation
dots = announcementsOpen · 1
Balance-sheet stress / refinancing
Cash runway and fundraising
Notice of intention to appoint administrators filed
Since October 2025 Trellus has run a very short runway, with advisers engaged, shares suspended from 8 May 2026 and removal from the AIM All-Share on 9 July 2026. On 12 August 2026 a $50,000 management loan extended runway to late August and advanced sale talks were discontinued. On 21 August 2026 the Board filed notice of intention to appoint Quantuma administrators, saying funds are insufficient. It expects no shareholder returns from any asset sale.
- Advisers
- Corporate restructuring advisers engaged; Board acting to protect wider stakeholders' interests 31 Jul 2026 ↗
- Mount Sinai loan
- $260,000 unsecured loan (19 June 2026); repayable earlier of 19 June 2027 or 90 days after a sale of Trellus Health Inc. 31 Jul 2026 ↗
- Loan
- US$50,000 unsecured, from executive management incl. US$20,000 from Dr. Marla Dubinsky (CEO) 12 Aug 2026 ↗
- Administrators
- Paul Zalkin and Tom Parish of Quantuma Advisory Ltd; notice of intention filed 21 August 2026 21 Aug 2026 ↗
- Timetable
- Board intends to appoint administrators within 5 business days, unless circumstances change 21 Aug 2026 ↗
- Reason
- Insufficient funds to continue trading as a going concern; action taken to protect creditors 21 Aug 2026 ↗
Next: Appointment of administrators; sale of assets incl. Trellus Health Inc. continues
- 21 Aug 2026 Notice of intention to appoint administrators filed
- 12 Aug 2026 Runway to late August; advanced sale talks collapsed
- 31 Jul 2026 Runway extended to 11 August; sale talks well advanced
- 6 Jul 2026 Shares suspended; removed from FTSE AIM All-Share
Closed · 1
Company filings. Not investment advice.